DFDA

Calcium Supplementation

Treatment for Premenstrual Syndrome

Typical Dosage: 1000-1200mg daily

Effectiveness
55%
Safety Score
85%
Clinical Trials
1
Participants
4K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
1000-1200mg daily
Time to Effect
2-3 months
Treatment Duration
Continuous
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$40
Monitoring:$600
Side Effect Mgmt:$10
Total Annual:$650
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$1,000/QALY
QALYs Gained
0.03
Outcome-Based Costs
Cost per Responder
$111
Cost per Remission
$250
Calcium Supplementation Outcomes

for Premenstrual Syndrome

Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+45%
Remission Rate
+20%
Common Side Effects
Constipation
+5%
Bloating
+3%

Sources:

clinmedkaz.org
clinmedkaz.org
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Calcium Supplementation in Premenstrual Syndrome

Effectiveness of Non-hormonal Treatment on Moderate to Severe Premenstrual Syndrome

NCT07078708COMPLETEDNA
View Study
100 participants
INTERVENTIONAL
Lahore, Pakistan
Started: Jun 1, 2024